Design, clinical translation and immunological response of biomaterials in regenerative medicine
Source abstract
Abstract
The field of regenerative medicine aims to replace tissues lost as a consequence of disease, trauma or congenital abnormalities. Biomaterials serve as scaffolds for regenerative medicine to deliver cells, provide biological signals and physical support, and mobilize endogenous cells to repair tissues. Sophisticated chemistries are used to synthesize materials that mimic and modulate native tissue microenvironments, to replace form and to elucidate structure–function relationships of cell–material interactions. The therapeutic relevance of these biomaterial properties can only be studied after clinical translation, whereby key parameters for efficacy can be defined and then used for future design. In this Review, we present the development and translation of biomaterials for two tissue engineering targets, cartilage and cornea, both of which lack the ability to self-repair. Finally, looking to the future, we discuss the role of the immune system in regeneration and the potential for biomaterial scaffolds to modulate immune signalling to create a pro-regenerative environment. The clinical translation of biomaterials for tissue engineering reveals their therapeutic performance and relevance, and thus enables the improvement of biomaterials design. In this Review, the design and translation of biomaterials, particularly cartilage and cornea repair, and a new understanding of the interaction between biomaterials and the host immune system are discussed.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Corneal Surgery and Treatments · Silk-based biomaterials and applications · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Thurston, A. J. Pare and prosthetics: the early history of artificial limbs. ANZ J. Surg. 77, 1114–1119 (2007).10.1111/j.1445-2197.2007.04330.x ↗
2. Mazzola, R. F. & Marcus, S. History of total nasal reconstruction with particular emphasis on the folded forehead flap technique. Plast. Reconstr. Surg. 72, 408–414 (1983).10.1097/00006534-198309000-00031 ↗
3. Langer, R. & Vacanti, J. P. Tissue engineering. Science 260, 920–926 (1993).10.1126/science.8493529 ↗
4. Langer, R. & Tirrell, D. A. Designing materials for biology and medicine. Nature 428, 487–492 (2004).10.1038/nature02388 ↗
5. Mikos, A. G. et al. Engineering complex tissues. Tissue Eng. 12, 3307–3339 (2006).10.1089/ten.2006.12.3307 ↗
6. Pashuck, E. T. & Stevens, M. M. Designing regenerative biomaterial therapies for the clinic. Sci. Transl. Med. 4, 160sr4 (2012).10.1126/scitranslmed.3002717 ↗
7. Macchiarini, P. et al. Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023–2030 (2008).10.1016/S0140-6736(08)61598-6 ↗
8. Warnke, P. H. et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364, 766–770 (2004).10.1016/S0140-6736(04)16935-3 ↗
9. Haraguchi, Y. et al. Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat. Protoc. 7, 850–858 (2012).10.1038/nprot.2012.027 ↗
10. Fennema, E., Rivron, N., Rouwkema, J., van Blitterswijk, C. & de Boer, J. Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 31, 108–115 (2013).10.1016/j.tibtech.2012.12.003 ↗
11. Liu, J. S. & Gartner, Z. J. Directing the assembly of spatially organized multicomponent tissues from the bottom up. Trends Cell Biol. 22, 683–691 (2012).10.1016/j.tcb.2012.09.004 ↗
12. Stevens, M. M. et al. In vivo engineering of organs: the bone bioreactor. Proc. Natl Acad. Sci. USA 102, 11450–11455 (2005).10.1073/pnas.0504705102 ↗
13. Lutolf, M. P. & Hubbell, J. A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47–55 (2005).10.1038/nbt1055 ↗
14. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).10.1126/science.284.5411.143 ↗
15. Ma, Z. et al. Self-organizing human cardiac microchambers mediated by geometric confinement. Nat. Commun. 6, 7413 (2015).10.1038/ncomms8413 ↗
16. Yang, C., Tibbitt, M. W., Basta, L. & Anseth, K. S. Mechanical memory and dosing influence stem cell fate. Nat. Mater. 13, 645–652 (2014).10.1038/nmat3889 ↗
17. Benoit, D. S., Schwartz, M. P., Durney, A. R. & Anseth, K. S. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat. Mater. 7, 816–823 (2008).10.1038/nmat2269 ↗
18. Singh, A., Zhan, J. A., Ye, Z. Y. & Elisseeff, J. H. Modular multifunctional poly(ethylene glycol) hydrogels for stem cell differentiation. Adv. Funct. Mater. 23, 575–582 (2013).10.1002/adfm.201201902 ↗
19. Kilian, K. A. & Mrksich, M. Directing stem cell fate by controlling the affinity and density of ligand–receptor interactions at the biomaterials interface. Angew. Chem. Int. Ed. Engl. 51, 4891–4895 (2012).10.1002/anie.201108746 ↗
20. Schense, J. C., Bloch, J., Aebischer, P. & Hubbell, J. A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat. Biotechnol. 18, 415–419 (2000).10.1038/74473 ↗
21. Hwang, N. S. et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc. Natl Acad. Sci. USA 105, 20641–20646 (2008).10.1073/pnas.0809680106 ↗
22. Lutolf, M. P., Gilbert, P. M. & Blau, H. M. Designing materials to direct stem-cell fate. Nature 462, 433–441 (2009).10.1038/nature08602 ↗
23. MacDonald, B. T., Tamai, K. & He, X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9–26 (2009).10.1016/j.devcel.2009.06.016 ↗
24. de Boer, J. et al. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34, 818–826 (2004).10.1016/j.bone.2004.01.016 ↗
25. Azarin, S. M. et al. Modulation of Wnt/β-catenin signaling in human embryonic stem cells using a 3D microwell array. Biomaterials 33, 2041–2049 (2012).10.1016/j.biomaterials.2011.11.070 ↗
26. Flaim, C. J., Chien, S. & Bhatia, S. N. An extracellular matrix microarray for probing cellular differentiation. Nat. Methods 2, 119–125 (2005).10.1038/nmeth736 ↗
27. Gobaa, S. et al. Artificial niche microarrays for probing single stem cell fate in high throughput. Nat. Methods 8, 949–955 (2011).10.1038/nmeth.1732 ↗
28. Somoza, R. A., Welter, J. F., Correa, D. & Caplan, A. I. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng. Part B Rev. 20, 596–608 (2014).10.1089/ten.teb.2013.0771 ↗
29. Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213, 341–347 (2007).10.1002/jcp.21200 ↗
30. Meirelles Lda, S., Fontes, A. M., Covas, D. T. & Caplan, A. I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419–427 (2009).10.1016/j.cytogfr.2009.10.002 ↗
31. Aggarwal, S. & Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815–1822 (2005).10.1182/blood-2004-04-1559 ↗
32. Schmalzried, T. P. & Callaghan, J. J. Wear in total hip and knee replacements. J. Bone Joint Surg. Am. 81, 115–136 (1999).10.2106/00004623-199901000-00016 ↗
33. Anderson, J. M. & Miller, K. M. Biomaterial biocompatibility and the macrophage. Biomaterials 5, 5–10 (1984).10.1016/0142-9612(84)90060-7 ↗
34. Anderson, J. M. Inflammatory response to implants. ASAIO Trans. 34, 101–107 (1988).10.1097/00002480-198804000-00005 ↗
35. Marchant, R. et al. In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel. J. Biomed. Mater. Res. 17, 301–325 (1983).10.1002/jbm.820170209 ↗
36. Marchant, R. E., Anderson, J. M., Phua, K. & Hiltner, A. In vivo biocompatibility studies. II. Biomer: preliminary cell adhesion and surface characterization studies. J. Biomed. Mater. Res. 18, 309–315 (1984).10.1002/jbm.820180307 ↗
37. Marchant, R. E., Miller, K. M. & Anderson, J. M. In vivo biocompatibility studies. V. In vivo leukocyte interactions with Biomer. J. Biomed. Mater. Res. 18, 1169–1190 (1984).10.1002/jbm.820180917 ↗
38. Marchant, R. E., Anderson, J. M. & Dillingham, E. O. In vivo biocompatibility studies. VII. Inflammatory response to polyethylene and to a cytotoxic polyvinylchloride. J. Biomed. Mater. Res. 20, 37–50 (1986).10.1002/jbm.820200105 ↗
39. Bauer, T. W., Geesink, R., Zimmerman, R. & McMahon, J. T. Hydroxyapatite-coated femoral stems. Histological analysis of components retrieved at autopsy. J. Bone Joint Surg. Am. 73, 1439–1452 (1991).10.2106/00004623-199173100-00001 ↗
40. Reid, B. et al. PEG hydrogel degradation and the role of the surrounding tissue environment. J. Tissue Eng. Regen. Med. 9, 315–318 (2013).10.1002/term.1688 ↗
41. Hillel, A. T. et al. Photoactivated composite biomaterial for soft tissue restoration in rodents and in humans. Sci. Transl. Med. 3, 93ra67 (2011).10.1126/scitranslmed.3002331 ↗
42. Gosselin, D. et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327–1340 (2014).10.1016/j.cell.2014.11.023 ↗
43. Lavin, Y. et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312–1326 (2014).10.1016/j.cell.2014.11.018 ↗
44. Beachley, V. Z. et al. Tissue matrix arrays for high-throughput screening and systems analysis of cell function. Nat. Methods 12, 1197–1204 (2015).10.1038/nmeth.3619 ↗
45. LaBarge, M. A. et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr. Biol. (Camb.) 1, 70–79 (2009).10.1039/B816472J ↗
46. Seliktar, D. Designing cell-compatible hydrogels for biomedical applications. Science 336, 1124–1128 (2012).10.1126/science.1214804 ↗
47. Saraf, A. et al. Fabrication of nonwoven coaxial fiber meshes by electrospinning. Tissue Eng. Part C Methods 15, 333–344 (2009).10.1089/ten.tec.2008.0422 ↗
48. Moutos, F. T., Freed, L. E. & Guilak, F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat. Mater. 6, 162–167 (2007).10.1038/nmat1822 ↗
49. Rnjak-Kovacina, J. et al. Lyophilized silk sponges: a versatile biomaterial platform for soft tissue engineering. ACS Biomater. Sci. Eng. 1, 260–270 (2015).10.1021/ab500149p ↗
50. Dahlin, R. L. et al. Articular chondrocytes and mesenchymal stem cells seeded on biodegradable scaffolds for the repair of cartilage in a rat osteochondral defect model. Biomaterials 35, 7460–7469 (2014).10.1016/j.biomaterials.2014.05.055 ↗
51. Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677–689 (2006).10.1016/j.cell.2006.06.044 ↗
52. Beck, J. N., Singh, A., Rothenberg, A. R., Elisseeff, J. H. & Ewald, A. J. The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination. Biomaterials 34, 9486–9495 (2013).10.1016/j.biomaterials.2013.08.077 ↗
53. Levorson, E. J., Santoro, M., Kasper, F. K. & Mikos, A. G. Direct and indirect co-culture of chondrocytes and mesenchymal stem cells for the generation of polymer/extracellular matrix hybrid constructs. Acta Biomater. 10, 1824–1835 (2014).10.1016/j.actbio.2013.12.026 ↗
54. Purcell, B. P. et al. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat. Mater. 13, 653–661 (2014).10.1038/nmat3922 ↗
55. Khetan, S. et al. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat. Mater. 12, 458–465 (2013).10.1038/nmat3586 ↗
56. Rape, A. D., Zibinsky, M., Murthy, N. & Kumar, S. A synthetic hydrogel for the high-throughput study of cell–ECM interactions. Nat. Commun. 6, 8129 (2015).10.1038/ncomms9129 ↗
57. Pace, L. A., Plate, J. F., Smith, T. L. & Van Dyke, M. E. The effect of human hair keratin hydrogel on early cellular response to sciatic nerve injury in a rat model. Biomaterials 34, 5907–5914 (2013).10.1016/j.biomaterials.2013.04.024 ↗
58. Wang, S. et al. A new nerve guide conduit material composed of a biodegradable poly(phosphoester). Biomaterials 22, 1157–1169 (2001).10.1016/S0142-9612(00)00356-2 ↗
59. Altman, G. H. et al. Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials 23, 4131–4141 (2002).10.1016/S0142-9612(02)00156-4 ↗
60. Vunjak-Novakovic, G., Altman, G., Horan, R. & Kaplan, D. L. Tissue engineering of ligaments. Annu. Rev. Biomed. Eng. 6, 131–156 (2004).10.1146/annurev.bioeng.6.040803.140037 ↗
61. Murphy, S. V. & Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32, 773–785 (2014).10.1038/nbt.2958 ↗
62. Lee, C. H. et al. Protein-releasing polymeric scaffolds induce fibrochondrocytic differentiation of endogenous cells for knee meniscus regeneration in sheep. Sci. Transl. Med. 6, 266ra171 (2014).10.1126/scitranslmed.3009696 ↗
63. Reiffel, A. J. et al. High-fidelity tissue engineering of patient-specific auricles for reconstruction of pediatric microtia and other auricular deformities. PLoS ONE 8, e56506 (2013).10.1371/journal.pone.0056506 ↗
64. DeForest, C. A. & Anseth, K. S. Cytocompatible click-based hydrogels with dynamically tunable properties through orthogonal photoconjugation and photocleavage reactions. Nat. Chem. 3, 925–931 (2011).10.1038/nchem.1174 ↗
65. Baskin, J. M. et al. Copper-free click chemistry for dynamic in vivo imaging. Proc. Natl Acad. Sci. USA 104, 16793–16797 (2007).10.1073/pnas.0707090104 ↗
66. Li, W. & Ding, S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol. Sci. 31, 36–45 (2010).10.1016/j.tips.2009.10.002 ↗
67. Chen, S., Zhang, Q., Wu, X., Schultz, P. G. & Ding, S. Dedifferentiation of lineage-committed cells by a small molecule. J. Am. Chem. Soc. 126, 410–411 (2004).10.1021/ja037390k ↗
68. Li, K. et al. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Cell Stem Cell 14, 228–236 (2014).10.1016/j.stem.2014.01.006 ↗
69. Gilbert, T. W., Sellaro, T. L. & Badylak, S. F. Decellularization of tissues and organs. Biomaterials 27, 3675–3683 (2006).
70. Badylak, S. F., Freytes, D. O. & Gilbert, T. W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 5, 1–13 (2009).10.1016/j.actbio.2008.09.013 ↗
71. Wolf, M. T., Dearth, C. L., Sonnenberg, S. B., Loboa, E. G. & Badylak, S. F. Naturally derived and synthetic scaffolds for skeletal muscle reconstruction. Adv. Drug Deliv. Rev. 84, 208–221 (2015).10.1016/j.addr.2014.08.011 ↗
72. Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell Proteomics 11, M111.014647 (2012).10.1074/mcp.M111.014647 ↗
73. Ahn, J. M. et al. Proteogenomic analysis of human chromosome 9-encoded genes from human samples and lung cancer tissues. J. Proteome Res. 13, 137–146 (2014).10.1021/pr400792p ↗
74. Murthy, K. R. et al. Proteomic analysis of human vitreous humor. Clin. Proteom. 11, 29 (2014).10.1186/1559-0275-11-29 ↗
75. Miller, J. S. et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 11, 768–774 (2012).10.1038/nmat3357 ↗
76. Liu, Q. et al. Porous nanofibrous poly(L-lactic acid) scaffolds supporting cardiovascular progenitor cells for cardiac tissue engineering. Acta Biomater. 26, 205–114 (2015).10.1016/j.actbio.2015.08.017 ↗
77. Anderson, J. M. Biological responses to materials. Annu. Rev. Mater. Res. 31, 81–110 (2001).10.1146/annurev.matsci.31.1.81 ↗
78. Anderson, J. M., Rodriguez, A. & Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. 20, 86–100 (2008).10.1016/j.smim.2007.11.004 ↗
79. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23–35 (2003).10.1038/nri978 ↗
80. Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303–7311 (2006).10.4049/jimmunol.177.10.7303 ↗
81. Bryers, J. D., Giachelli, C. M. & Ratner, B. D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol. Bioeng. 109, 1898–1911 (2012).10.1002/bit.24559 ↗
82. Brown, B. N., Ratner, B. D., Goodman, S. B., Amar, S. & Badylak, S. F. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 33, 3792–3802 (2012).10.1016/j.biomaterials.2012.02.034 ↗
83. Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14–20 (2014).10.1016/j.immuni.2014.06.008 ↗
84. Otis, J. S. et al. Pro-inflammatory mediation of myoblast proliferation. PLoS ONE 9, e92363 (2014).10.1371/journal.pone.0092363 ↗
85. Tidball, J. G. & Villalta, S. A. Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1173–1187 (2010).10.1152/ajpregu.00735.2009 ↗
86. Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nat. Immunol. 8, 11–13 (2007).10.1038/ni0107-11 ↗
87. Matzinger, P. & Kamala, T. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11, 221–230 (2011).10.1038/nri2940 ↗
88. Ma, J. et al. Regulation of macrophage activation. Cell. Mol. Life Sci. 60, 2334–2346 (2003).10.1007/s00018-003-3020-0 ↗
89. Rengarajan, J., Szabo, S. J. & Glimcher, L. H. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today 21, 479–483 (2000).10.1016/S0167-5699(00)01712-6 ↗
90. Godwin, J. W., Pinto, A. R. & Rosenthal, N. A. Macrophages are required for adult salamander limb regeneration. Proc. Natl Acad. Sci. USA 110, 9415–9420 (2013).10.1073/pnas.1300290110 ↗
91. Heredia, J. E. et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153, 376–388 (2013).10.1016/j.cell.2013.02.053 ↗
92. Sadtler, K. et al. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells. Science 352, 366–370 (2016).10.1126/science.aad9272 ↗
93. McNally, A. K. & Anderson, J. M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. Pathol. 147, 1487–1499 (1995).
94. Epelman, S., Liu, P. P. & Mann, D. L. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat. Rev. Immunol. 15, 117–129 (2015).10.1038/nri3800 ↗
95. Schlundt, C. et al. Macrophages in bone fracture healing: their essential role in endochondral ossification. Bonehttp://dx.doi.org/10.1016/j.bone.2015.10.019 (2015).10.1016/j.bone.2015.10.019 ↗
96. Konnecke, I. et al. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. Bone 64, 155–165 (2014).10.1016/j.bone.2014.03.052 ↗
97. Reinke, S. et al. Terminally differentiated CD8+ T cells negatively affect bone regeneration in humans. Sci. Transl. Med. 5, 177ra36 (2013).10.1126/scitranslmed.3004754 ↗
98. Gaudilliere, B. et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci. Transl. Med. 6, 255ra131 (2014).10.1126/scitranslmed.3009701 ↗
99. Guilak, F. et al. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 5, 17–26 (2009).10.1016/j.stem.2009.06.016 ↗
100. Khademhosseini, A. & Langer, R. Microengineered hydrogels for tissue engineering. Biomaterials 28, 5087–5092 (2007).10.1016/j.biomaterials.2007.07.021 ↗